Data / Form D filings / Rhoshan Pharmaceuticals, Inc.
Rhoshan Pharmaceuticals, Inc.: Form D filings
Rhoshan Pharmaceuticals, Inc., a pharmaceuticals company in State College, PA, filed 5 Form D notices with the SEC between 2018 and 2026. The latest, on July 22, 2026, reports $3.1 million sold of a $3.2 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 19 COLONNADE WAY SUITE 117, BOX 141, State College, PA, 16803
- Phone
- (206) 499-7284
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1756479
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | Amendment | $3,158,776 | $3,099,969 | $58,807 | 4 | Sep 18, 2023 | sec.gov |
| Sep 11, 2024 | Amendment | $1,758,793 | $1,699,986 | $58,807 | 3 | Sep 18, 2023 | sec.gov |
| Sep 22, 2023 | New notice | $758,800 | $149,995 | $608,805 | 1 | Sep 18, 2023 | sec.gov |
| Sep 23, 2019 | New notice | $1,499,994 | $1,374,981 | $125,013 | 5 | Mar 18, 2019 | sec.gov |
| Dec 27, 2018 | New notice | $19,325,000 | $19,325,000 | 0 | Dec 21, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Hitha Palepu | Executive Officer, Director | |
| Nagesh Palepu | Director | |
| Allan Clarke | Executive Officer, Director | |
| Charlene Messinger | Executive Officer |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Jul 20, 2026 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Rhoshan Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.